The role of angiogenic factors and their soluble receptors in acute lung injury (ALI)/ acute respiratory distress syndrome (ARDS) associated with critical illness

Journal of Inflammation

Research

Asumi Mizugaki¹  Hiroyuki Yokota¹  Satoshi Gando²  Yuichiro Yanagida²  Takeshi Wada²  Subrina Jesmin³  Sohel Zaedi⁴  Sayeeda Nusrat Sultana⁴ 

[1] Department of Emergency and Critical Care Medicine, Nippon Medical School, 1-1-5 Sendagi Bunkyo-ku, 113-8603, Tokyo, Japan;Division of Acute and Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Hokkaido University Graduate School of Medicine, N17W5, Kita-ku, 060-8638, Sapporo, Hokkaido, Japan;Division of Acute and Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Hokkaido University Graduate School of Medicine, N17W5, Kita-ku, 060-8638, Sapporo, Hokkaido, Japan;Deparment of Emergency and Critical Care Medicine, Faculty of Medicine, University of Tsukuba, 1-1-1, Tennoudai, 305-8575, Tsukuba, Ibaraki, Japan;Health and Diseases Research Center for Rural Peoples (HDRCRP), 14/15, 1st floor, Probal Housing Ltd., Shekertak (Adjacent to Shekertak Road 1), 1207, Mohammadpur, Dhaka, Bangladesh;Health and Diseases Research Center for Rural Peoples (HDRCRP), 14/15, 1st floor, Probal Housing Ltd., Shekertak (Adjacent to Shekertak Road 1), 1207, Mohammadpur, Dhaka, Bangladesh;

关键词: Acute lung injury;    Acute respiratory distress syndrome;    Angiogenic factors;    Vascular endothelial growth factor;    Angiopoietin;    Outcome;   

DOI  :  10.1186/1476-9255-10-6

 received in 2012-10-26, accepted in 2013-02-08,  发布年份 2013

来源: Springer

【 摘 要 】

BackgroundAcute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are characterized by a disruption of the endothelium and alveolar epithelial barriers involving increased microvascular permeability, thus resulting in the set of protein-rich pulmonary edema. Angiogenic factors and their receptors, including vascular endothelial growth factor (VEGF)/VEGF-receptor (VEGFR) and the angiopoietin (Ang)/Tie2 signaling pathways, play pivotal roles in both angiogenesis and microvascular permeability. The aim of the study was to assess the relationship between angiogenic factors, their soluble receptors and ALI/ARDS associated with critically ill patients, including sepsis, severe trauma, and post-cardiac arrest syndrome (PCAS).MethodsOne hundred fifty-nine critically ill patients, including 50 patients with sepsis, 57 patients with severe trauma and 52 resuscitated after out-of-hospital cardiac arrest, were divided into three subgroups: including 25 ALI patients, 101 ARDS patients and 22 non-ALI/ARDS patients. The serum levels of angiogenic factors were measured at the time of admission (day 1), as well as day 3 and day 5 and then were compared among the ALI, ARDS and non-ALI/ARDS groups. Their predictive values for developing ALI/ARDS and 28-day mortality were evaluated.ResultsHigher levels of sVEGFR1 and Ang2 were observed in the ALI and ARDS patients than in the non-ALI/ARDS patients during the entire study period. The Ang2/Ang1 ratio in the ARDS group was also significantly higher than that in the non-ALI/ADRS group. The sVEGFR2 levels in the ARDS group on day 1 were significantly lower than those of the non-ALI/ADRS group. In addition, significant positive correlations were seen between the sVEGFR1, Ang2, Ang2/Ang1, and the development of ALI/ARDS in critical illness. There were also significant negative correlations between the minimal value of sVEGFR2, the maximal value of Ang1 and the ALI/ARDS group. In particular, sVEGFR2 and Ang2 were independent predictors of developing ALI/ARDS. Moreover, Ang2 and sVEGFR2 also independently predicted the mortality in ALI/ARDS patients.ConclusionsAngiogenic factors and their soluble receptors, particularly sVEGFR2 and Ang2, are thus considered to be valuable predictive biomarkers in the development of ALI/ARDS associated with critical illness and mortality in ALI/ARDS patients.

【 授权许可】

Unknown   
© Wada et al.; licensee BioMed Central Ltd. 2013. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.